Genetics of Neonatal Lupus Erythematosus Risk and Specific Manifestations

M.C. Misztal, MHSc, Genetics & Genome Biology, Research Institute, The Hospital for Sick Children.
N. Gold, MSc, Genetics & Genome Biology, Research Institute, The Hospital for Sick Children.
J Cao, MSc, Genetics & Genome Biology, Research Institute, The Hospital for Sick Children.
T. Diaz, MD; Division of Rheumatology, The Hospital for Sick Children; Departamento de Pediatría, Hospital San José, Tecnológico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey, Nuevo León, México.
D. Dominguez, MSc; Division of Rheumatology, The Hospital for Sick Children.
K. Thompson, BSc, Genetics & Genome Biology, Research Institute, The Hospital for Sick Children.
E. Jaeggi, MD, Division of Rheumatology, The Hospital for Sick Children.
A.M. Knight, MD; Division of Rheumatology, The Hospital for Sick Children.
C. Laskin, MD; Division of Rheumatology, The Hospital for Sick Children.
L. Ng, BSc; Division of Rheumatology, The Hospital for Sick Children.
E.D. Silverman, MD; Division of Rheumatology, The Hospital for Sick Children.
L.T. Hiraki, MD, ScD, Genetics & Genome Biology, Research Institute, The Hospital for Sick Children; Division of Rheumatology, The Hospital for Sick Children.

The source(s) of support in the form of grants or industrial support: Dr. Hiraki is supported by a CIHR Canada Research Chair and The Arthritis Society STARS Career Development award.
Conflict of Interest: All authors report no potential conflicts of interest.
Statement of ethics and consent: Informed patient consent was obtained and all aspects of this study were approved by the Institutional Research Ethics Board (REB no. 1000034004).

Correspondence: Linda T. Hiraki, MD, FRCPC, ScD, Clinician Scientist, Division of Rheumatology, Scientist Track, Research Institute, The Hospital for Sick Children, PGCRL, 686 Bay Street | Toronto ON M5G 0A4. Email: linda.hiraki@sickkids.ca

Article usage